Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$29.35 - $34.19 $349,587 - $407,237
-11,911 Closed
0 $0
Q1 2022

May 12, 2022

BUY
$32.56 - $40.56 $12,893 - $16,061
396 Added 3.44%
11,911 $403,000
Q4 2021

Feb 11, 2022

BUY
$36.93 - $42.14 $89,407 - $102,020
2,421 Added 26.62%
11,515 $485,000
Q3 2021

Nov 12, 2021

BUY
$35.36 - $44.01 $191,969 - $238,930
5,429 Added 148.13%
9,094 $372,000
Q2 2021

Aug 11, 2021

BUY
$29.45 - $35.85 $3,416 - $4,158
116 Added 3.27%
3,665 $130,000
Q1 2021

May 14, 2021

SELL
$26.83 - $30.69 $22.1 Million - $25.3 Million
-823,951 Reduced 99.57%
3,549 $103,000
Q4 2020

Feb 12, 2021

BUY
$22.9 - $28.15 $18.9 Million - $23.3 Million
827,500 New
827,500 $23.3 Million

Others Institutions Holding AVTR

About Avantor, Inc.


  • Ticker AVTR
  • Exchange NYSE
  • Sector Basic Materials
  • Industry Specialty Chemicals
  • Shares Outstandng 674,035,008
  • Market Cap $14.1B
  • Description
  • Avantor, Inc. provides products and services to customers in biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulate...
More about AVTR
Track This Portfolio

Track Friess Associates LLC Portfolio

Follow Friess Associates LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Friess Associates LLC, based on Form 13F filings with the SEC.

News

Stay updated on Friess Associates LLC with notifications on news.